Literature DB >> 6509037

Occurrence of novel antigenic phosphoinositol-containing sphingolipids in the pathogenic yeast Histoplasma capsulatum.

K Barr, R L Lester.   

Abstract

Five alkali-stable lipids from the yeast phase of Histoplasma capsulatum have been purified and analyzed. Each compound has equimolar amounts of hydroxysphinganine (phytosphingosine) and a hydroxy or nonhydroxy 24:0 fatty acid. All yield inositol phosphate after acid hydrolysis, and several are novel in that they also yield dimannosylinositol (compound V) and isomeric galactosyldimannosylinositols (compounds VI and VIII) after strong ammonolysis. The foregoing as well as other data suggest that compound V is a dimannosylinositolphosphoceramide and compounds VI and VIII are galactosyldimannosylinositolphosphoceramides with isomeric head groups. The chromatographic behavior of compounds II and III indicates that they are similar to the inositolphosphoceramides previously observed in Saccharomyces cerevisiae. Compounds V and VI are virtually absent from the mycelial phase of H. capsulatum. Antibodies that react with compounds V, VI, and VIII have been detected in sera from patients with histoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6509037     DOI: 10.1021/bi00318a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Substrate recognition by Escherichia coli MutY using substrate analogs.

Authors:  C L Chepanoske; S L Porello; T Fujiwara; H Sugiyama; S S David
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

3.  Interaction of murine macrophage-membrane proteins with components of the pathogenic fungus Histoplasma capsulatum.

Authors:  M L Taylor; E Duarte-Escalante; M R Reyes-Montes; N Elizondo; G Maldonado; E Zenteno
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

4.  Isolation of mutant Saccharomyces cerevisiae strains that survive without sphingolipids.

Authors:  R C Dickson; G B Wells; A Schmidt; R L Lester
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

5.  Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPC.

Authors:  Marcos S Toledo; Loriane Tagliari; Erika Suzuki; Claudinei M Silva; Anita H Straus; Helio K Takahashi
Journal:  BMC Microbiol       Date:  2010-02-15       Impact factor: 3.605

6.  Inhibition of murine macrophage protein kinase C activity by nonviable Histoplasma capsulatum.

Authors:  J E Wolf; S E Massof; J R Sherwin; R V Considine
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

7.  Surface architecture of histoplasma capsulatum.

Authors:  Allan J Guimarães; Mariana D de Cerqueira; Joshua D Nosanchuk
Journal:  Front Microbiol       Date:  2011-11-18       Impact factor: 5.640

8.  Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages.

Authors:  W E Bullock; S D Wright
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

Review 9.  Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi.

Authors:  Luciana L Guimarães; Marcos S Toledo; Felipe A S Ferreira; Anita H Straus; Helio K Takahashi
Journal:  Front Cell Infect Microbiol       Date:  2014-09-25       Impact factor: 5.293

Review 10.  Biological Roles Played by Sphingolipids in Dimorphic and Filamentous Fungi.

Authors:  Caroline Mota Fernandes; Gustavo H Goldman; Maurizio Del Poeta
Journal:  mBio       Date:  2018-05-15       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.